Sonic Healthcare Limited
SHL
주식 순위
#2828
Sonic Healthcare Limited delivers medical diagnostic services to a diverse... Sonic Healthcare Limited delivers medical diagnostic services to a diverse clientele, including medical professionals, hospitals, public health organizations, and individual patients. The company's services encompass a broad spectrum of laboratory medicine and pathology testing, covering biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal diagnostics, toxicology, and other related functions. Furthermore, Sonic provides extensive radiology services, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Its offerings also extend to primary care medical services, featuring general practice clinics, occupational health, specialized skin cancer clinics, after-hours GP services, IT solutions for general practices, and various community-based healthcare programs. Operating internationally, the company has a significant presence in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, and Belgium. Founded in 1934, Sonic Healthcare Limited is headquartered in Sydney, Australia.
주가
$13.26
시가총액
$6.55B
변동 (1일)
-0.21%
변동 (1년)
-4.48%
국가
AU
거래 Sonic Healthcare Limited (SHL)
카테고리
Healthcare
Sonic Healthcare Limited (SHL)의 매출
Jun 2026 기준 매출 TTM: $7.72B
Sonic Healthcare Limited의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $7.72B입니다. 2024년에 회사는 $5.97B의 수익을 올렸으며 이는 2023년의 $5.43B 대비 증가입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Sonic Healthcare Limited의 수익 기록 (2000 ~ 2026)
매년 말 매출
| 연도 | 매출 | 변화 |
|---|---|---|
| 2026 (TTM) | $7.72B | 21.62% |
| 2025 | $6.35B | 6.44% |
| 2024 | $5.97B | 9.92% |
| 2023 | $5.43B | -15.46% |
| 2022 | $6.42B | -2.19% |
| 2021 | $6.56B | 44.93% |
| 2020 | $4.53B | 5.12% |
| 2019 | $4.31B | 6.21% |
| 2018 | $4.06B | 4.22% |
| 2017 | $3.89B | 5.59% |
| 2016 | $3.69B | 15.59% |
| 2015 | $3.19B | -12.32% |
| 2014 | $3.64B | 16.17% |
| 2013 | $3.13B | -7.83% |
| 2012 | $3.40B | 2.73% |
| 2011 | $3.31B | 31.31% |
| 2010 | $2.52B | 4.80% |
| 2009 | $2.40B | 7.41% |
| 2008 | $2.24B | 42.62% |
| 2007 | $1.57B | 29.80% |
| 2006 | $1.21B | 16.78% |
| 2005 | $1.03B | 45.21% |
| 2004 | $712.48M | 10.16% |
| 2003 | $646.79M | 35.18% |
| 2002 | $478.47M | 51.42% |
| 2001 | $315.99M | 0.00% |
| 2000 | 0.00 | 0.00% |
유사 기업 또는 경쟁사의 매출
| 회사 | 매출 | 매출 차이 | 국가 |
|---|---|---|---|
| $46.34B | 499.99% |
US
|
|
| $25.11B | 225.10% |
US
|
|
| $2.71B | -64.95% |
US
|
|
| - | - |
CN
|
|
| $7.37B | -4.54% |
US
|
